Company intelligence / Profile preview

RetiSpec

Toronto, Ontario, Canadaretispec.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

RetiSpec has developed a non-invasive diagnostic platform using hyperspectral retinal imaging combined with artificial intelligence to detect early signs of Alzheimer’s disease by identifying amyloid beta protein signatures in the retina. The company’s device and software are undergoing pivotal studies to support FDA clearance. Early results show strong correlation between their test and PET brain amyloidosis status, supporting its use as a scalable screening tool for preclinical Alzheimer’s detection. Commercialization activities are ongoing with recent funding secured to advance regulatory approval and market launch.

Therapeutic areas
Neurology
Modalities
DeviceArtificial intelligence softwareNon-pharmacological therapy (diagnostic)
Industry
Medical Imaging
02

Partnerships

Topcon Healthcare Inc.optometry clinics across Canada and the US for real-world data collection

Beyond the preview

Go deeper on RetiSpec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RetiSpec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call